Stiffness is more than just duration and severity: a qualitative exploration in people with rheumatoid arthritis.

Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary. J Rheumatol (2015) 0.82

More than Just Minutes of Stiffness in the Morning: Report from the OMERACT Rheumatoid Arthritis Flare Group Stiffness Breakout Sessions. J Rheumatol (2015) 0.80

Characterising those with incident polymyalgia rheumatica in primary care: results from the PMR Cohort Study. Arthritis Res Ther (2016) 0.79

Patient reported outcomes in rheumatoid arthritis clinical trials. Curr Rheumatol Rep (2015) 0.77

Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis. Drug Des Devel Ther (2016) 0.75

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05

Rigour and qualitative research. BMJ (1995) 22.49

Measurement of patient outcome in arthritis. Arthritis Rheum (1980) 21.31

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis (2010) 10.03

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum (1993) 8.73

Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum (1981) 5.24

Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol (1993) 4.62

Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument. Value Health (2011) 3.63

Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding. Value Health (2011) 3.45

Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health (2007) 3.16

Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet (2008) 2.99

Defining morning stiffness in rheumatoid arthritis. J Rheumatol (1999) 2.12

Patients and professionals as research partners: challenges, practicalities, and benefits. Arthritis Rheum (2006) 1.95

Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice? J Rheumatol (2006) 1.92

'I'm hurting, I want to kill myself': rheumatoid arthritis flare is more than a high joint count--an international patient perspective on flare where medical help is sought. Rheumatology (Oxford) (2011) 1.92

Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol (2007) 1.87

Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum (2007) 1.78

Morning stiffness in rheumatoid arthritis. Ann Rheum Dis (1960) 1.68

Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus. Ann Rheum Dis (2012) 1.62

Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis (2008) 1.57

Clinical judgment in rheumatoid arthritis. III. British rheumatologists' judgments of 'change in response to therapy'. Ann Rheum Dis (1984) 1.33

Overnight variations in cortisol, interleukin 6, tumour necrosis factor alpha and other cytokines in people with rheumatoid arthritis. Ann Rheum Dis (2008) 1.19

Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis. Rheumatology (Oxford) (2008) 1.10

Assessment of stiffness in rheumatology: the use of rating scales. Br J Rheumatol (1987) 1.10

Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop. J Rheumatol (2011) 1.05

Measuring fatigue in rheumatoid arthritis: a cross-sectional study to evaluate the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional questionnaire, visual analog scales, and numerical rating scales. Arthritis Care Res (Hoboken) (2010) 1.05

The impact triad (severity, importance, self-management) as a method of enhancing measurement of personal life impact of rheumatic diseases. J Rheumatol (2011) 0.99

Collaboration with patients in the design of patient-reported outcome measures: capturing the experience of fatigue in rheumatoid arthritis. Arthritis Care Res (Hoboken) (2010) 0.99

Measurement of morning stiffness in rheumatoid arthritis clinical trials. J Clin Epidemiol (1997) 0.99

A reevaluation of the symptom of morning stiffness. J Rheumatol (1993) 0.96

The patient perspective on remission in rheumatoid arthritis: 'You've got limits, but you're back to being you again'. Ann Rheum Dis (2014) 0.96

Impact of impaired morning function on the lives and well-being of patients with rheumatoid arthritis. Scand J Rheumatol Suppl (2011) 0.94

Reevaluation of the role of duration of morning stiffness in the assessment of rheumatoid arthritis activity. J Rheumatol (2009) 0.93

Reliability and sensitivity to change of the Bristol Rheumatoid Arthritis Fatigue scales. Rheumatology (Oxford) (2013) 0.83

Measurement of stiffness in patients with rheumatoid arthritis in low disease activity or remission: a systematic review. BMC Musculoskelet Disord (2014) 0.82